Summary

The Global Lateral Flow Assays Market, valued at approximately USD 9.85 billion in 2024, is anticipated to witness a robust compound annual growth rate of about 5.99% over the forecast period 2025-2035. Lateral Flow Assays (LFAs) represent a rapid, portable, and user-friendly diagnostic solution that has revolutionized point-of-care testing across diverse sectors, from infectious disease detection to food safety and veterinary diagnostics. Built on a simple yet highly effective mechanism of capillary action, these devices deliver quick results without the need for complex laboratory infrastructure, making them indispensable in both developed and emerging healthcare settings. The surge in chronic and infectious disease prevalence, coupled with rising consumer demand for home-based testing solutions and government-led initiatives to strengthen public health surveillance, has been pivotal in accelerating market momentum. In parallel, ongoing innovation in assay sensitivity, multiplexing capabilities, and digital reader integration is broadening the scope of applications, thereby cementing LFAs as a critical pillar in modern diagnostic ecosystems.
The rapid expansion of this market has been further catalyzed by the convergence of technological sophistication and pressing healthcare demands. A growing global population, coupled with heightened awareness regarding early disease detection, has intensified the call for rapid diagnostics in both clinical and non-clinical environments. According to industry reports, the post-pandemic era has underscored the urgency for decentralized testing, encouraging healthcare systems worldwide to adopt LFAs as a cost-effective and scalable solution. Moreover, their adaptability to diverse assay formats—such as sandwich and competitive assays—has enabled manufacturers to cater to specialized testing needs across infectious diseases, pregnancy testing, cardiac markers, and drug-of-abuse screening. However, the sector also faces competitive pressure from molecular diagnostic techniques, which, while more expensive, offer higher accuracy in certain scenarios—posing a moderate challenge to the growth trajectory.
From a geographical standpoint, North America currently commands the largest market share, bolstered by advanced healthcare infrastructure, significant R&D investment, and the early adoption of innovative diagnostic technologies. The region’s strong regulatory framework, coupled with the presence of leading diagnostic players, further amplifies market penetration. Europe follows closely, driven by robust healthcare funding and an increasing emphasis on preventive diagnostics across both public and private sectors. Meanwhile, Asia Pacific is emerging as the fastest-growing region, fueled by rapid urbanization, rising healthcare expenditure, and an expanding middle-class demographic in nations like China and India. Governments in these markets are actively endorsing point-of-care testing to bridge healthcare access gaps, while local manufacturers are capitalizing on cost advantages to produce affordable LFA solutions for both domestic and export markets. Latin America and the Middle East & Africa are also projected to witness steady growth, propelled by gradual improvements in healthcare delivery systems and increased awareness of early disease detection benefits.
Major market player included in this report are:
• Abbott Laboratories
• F. Hoffmann-La Roche AG
• Thermo Fisher Scientific Inc.
• Becton, Dickinson and Company
• QuidelOrtho Corporation
• Siemens Healthineers AG
• bioMérieux SA
• PerkinElmer Inc.
• Danaher Corporation
• Bio-Rad Laboratories Inc.
• Qiagen N.V.
• Hologic Inc.
• Merck KGaA
• Chembio Diagnostics, Inc.
• Abcam plc
Global Lateral Flow Assays Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period - 2025-2035
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent up to 8 analysts’ working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:
By Product:
• Kits
• Lateral Flow Readers
By Technique:
• Sandwich Assays
• Competitive Assays
By Application:
• (Detailed breakdowns as per market study)
By Test:
• (Detailed breakdowns as per market study)
By End Use:
• (Detailed breakdowns as per market study)
By Region:
North America
• U.S.
• Canada
Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
Latin America
• Brazil
• Mexico
Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa
Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1. Global Lateral Flow Assays Market Report Scope & Methodology
1.1. Research Objective
1.2. Research Methodology
1.2.1. Forecast Model
1.2.2. Desk Research
1.2.3. Top Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
1.4.1. Market Definition
1.4.2. Market Segmentation
1.5. Research Assumption
1.5.1. Inclusion & Exclusion
1.5.2. Limitations
1.5.3. Years Considered for the Study
Chapter 2. Executive Summary
2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. Key Findings
Chapter 3. Global Lateral Flow Assays Market Forces Analysis
3.1. Market Forces Shaping The Global Lateral Flow Assays Market (2024-2035)
Drivers
3.2.1. Increasing prevalence of chronic and infectious diseases driving point-of-care diagnostics adoption
3.2.2. Rising demand for home-based testing kits and decentralized healthcare solutions
3.2.3. Technological advancements in assay sensitivity, multiplexing, and digital integration
Restraints
3.3.1. Competition from advanced molecular diagnostic technologies offering higher accuracy
3.3.2. Regulatory compliance complexities across multiple regions
Opportunities
3.4.1. Expansion of LFA applications into emerging diagnostic segments such as cardiac markers and drug-of-abuse testing
3.4.2. Rising healthcare investments and infrastructure development in emerging markets
Chapter 4. Global Lateral Flow Assays Industry Analysis
4.1. Porter’s 5 Forces Model
4.1.1. Bargaining Power of Buyer
4.1.2. Bargaining Power of Supplier
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Forecast Model (2024-2035)
4.3. PESTEL Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024-2025)
4.7. Global Pricing Analysis And Trends 2025
4.8. Analyst Recommendation & Conclusion
Chapter 5. Global Lateral Flow Assays Market Size & Forecasts by Product 2025-2035
5.1. Market Overview
5.2. Global Lateral Flow Assays Market Performance - Potential Analysis (2025)
5.3. Kits
5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
5.3.2. Market size analysis, by region, 2025-2035
5.4. Lateral Flow Readers
5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
5.4.2. Market size analysis, by region, 2025-2035
Chapter 6. Global Lateral Flow Assays Market Size & Forecasts by Technique 2025–2035
6.1. Market Overview
6.2. Global Lateral Flow Assays Market Performance - Potential Analysis (2025)
6.3. Sandwich Assays
6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
6.3.2. Market size analysis, by region, 2025-2035
6.4. Competitive Assays
6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
6.4.2. Market size analysis, by region, 2025-2035
Chapter 7. Global Lateral Flow Assays Market Size & Forecasts by Application 2025–2035
7.1. Market Overview
7.2. Global Lateral Flow Assays Market Performance - Potential Analysis (2025)
7.3. (Application Segment 1)
7.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
7.3.2. Market size analysis, by region, 2025-2035
7.4. (Application Segment 2)
7.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
7.4.2. Market size analysis, by region, 2025-2035
Chapter 8. Global Lateral Flow Assays Market Size & Forecasts by Test 2025–2035
8.1. Market Overview
8.2. (Test Segment 1)
8.2.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
8.2.2. Market size analysis, by region, 2025-2035
8.3. (Test Segment 2)
8.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
8.3.2. Market size analysis, by region, 2025-2035
Chapter 9. Global Lateral Flow Assays Market Size & Forecasts by End Use 2025–2035
9.1. Market Overview
9.2. (End Use Segment 1)
9.2.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
9.2.2. Market size analysis, by region, 2025-2035
9.3. (End Use Segment 2)
9.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
9.3.2. Market size analysis, by region, 2025-2035
Chapter 10. Global Lateral Flow Assays Market Size & Forecasts by Region 2025–2035
10.1. Lateral Flow Assays Market, Regional Market Snapshot
10.2. Top Leading & Emerging Countries
North America
10.3.1. U.S.
10.3.1.1. Product breakdown size & forecasts, 2025-2035
10.3.1.2. Technique breakdown size & forecasts, 2025-2035
10.3.2. Canada
10.3.2.1. Product breakdown size & forecasts, 2025-2035
10.3.2.2. Technique breakdown size & forecasts, 2025-2035
Europe
(UK, Germany, France, Spain, Italy, Rest of Europe — all with product & technique breakdowns)
Asia Pacific
(China, India, Japan, Australia, South Korea, Rest of APAC — all with product & technique breakdowns)
Latin America
(Brazil, Mexico — both with product & technique breakdowns)
Middle East & Africa
(UAE, Saudi Arabia, South Africa — all with product & technique breakdowns)
Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2–11.16. Company Profiles (Abbott, Roche, Thermo Fisher, BD, QuidelOrtho, Siemens Healthineers, bioMérieux, PerkinElmer, Danaher, Bio-Rad, Qiagen, Hologic, Merck KGaA, Chembio Diagnostics, Abcam)